Ana Camacho Carrasco

Ana Camacho Carrasco

Auto-generated profile, based on publicly available information

Ana Camacho Carrasco


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MRManuel Jesús Romero-Jiménez
Manuel Jesús Romero-Jiménez
EGEva N Gutiérrez-Cortizo
Eva N Gutiérrez-Cortizo
SGSoraya Sánchez González
Soraya Sánchez González
ACAna Camacho Carrasco
Ana Camacho Carrasco
MLMiguel Angel Castaño López
Miguel Angel Castaño López
EEElena Bonet Estruch
Elena Bonet Estruch
Background and aims: Current population-based data on cardiovascular risk and lipid target achievement in Mediterranean populations are limited. We assessed cardiovascular risk, lipid-lowering treatment, and low-density lipoprotein cholesterol control in the province of Huelva, southern Spain.Methods: MAPA-Huelva was a cross-sectional, population-based study of 318 participants selected using stratified random sampling. Cardiovascular risk was classified according to 2021 European Society of Cardiology criteria using SCORE2, SCORE2-OP, and, when applicable, SCORE2-Diabetes. Attainment of risk-specific absolute low-density lipoprotein cholesterol goals was assessed.Results: Hypertension, diabetes, and dyslipidaemia were present in 43.1%, 13.8%, and 46.2% of participants, respectively. Among classifiable participants, 32.3% were at high or very high risk. Lipid-lowering therapy use increased across risk categories (9.2%, 23.9%, 51.8%, and 71.8%; p <0.001), whereas low-density lipoprotein cholesterol goal attainment decreased (61.4%, 24.4%, 14.8%, and 15.8%; p <0.001). Only 15.2% of high- or very-high-risk participants with available low-density lipoprotein cholesterol attained their goal; among those above goal, 46.2% were untreated. In exploratory adjusted analysis, older age and current smoking were associated with goal non-attainment, whereas lipid-lowering therapy was associated with lower odds of being above goal (odds ratio 0.15, 95% confidence interval 0.06–0.37; p<0.001).Conclusions: Almost one-third of classifiable participants in this contemporary Mediterranean population were at high or very high cardiovascular risk. Gaps in treatment initiation, intensity, and low-density lipoprotein cholesterol goal attainment support more systematic implementation of guideline-directed lipid management.

16 October 2026 in Journal of Clinical Lipidology
Verified
Journal Article
Open access
JRJosé Rioja
José Rioja
DCDaniel de la Cueva-Genovés
Daniel de la Cueva-Genovés
MAMaria J. Ariza
Maria J. Ariza
RORosa María Ordóñez-Simón
Rosa María Ordóñez-Simón
MBMaría José Benítez-Toledo
María José Benítez-Toledo
MSMiguel Ángel Sánchez-Chaparro
Miguel Ángel Sánchez-Chaparro